HCG
Haven Capital Group Portfolio holdings
AUM
$112M
1-Year Est. Return
33.82%
1 Year Est. Return
+33.82%
AUM
$112M
AUM Growth
-$1.15M
(-1%)
Holding
43
Top Buys
| 1 | +$432K | |
| 2 | +$432K | |
| 3 | +$211K | |
| 4 |
Expeditors International
EXPD
|
+$205K |
| 5 |
Marriott International
MAR
|
+$40.9K |
Top Sells
| 1 | +$4.25M | |
| 2 | +$2.07M | |
| 3 | +$1.03M | |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$697K |
| 5 |
Equinix
EQIX
|
+$509K |
Sector Composition
| 1 | Technology | 61.06% |
| 2 | Healthcare | 20.5% |
| 3 | Consumer Discretionary | 7.27% |
| 4 | Materials | 3.59% |
| 5 | Industrials | 3.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nike
NKE
$97B
| $522K | 0.46% |
7,480
-11
|
|
||
27
Zebra Technologies
ZBRA
$12.8B
| $469K | 0.42% |
1,579
-97
|
|
||
28
Gilead Sciences
GILD
$151B
| $443K | 0.39% |
3,987
|
|
||
29
Bristol-Myers Squibb
BMY
$109B
| $354K | 0.32% |
7,839
|
|
||
30
Advanced Micro Devices
AMD
$327B
| $298K | 0.27% |
1,839
-45
|
|
||
31
Emerson Electric
EMR
$74B
| $275K | 0.24% |
2,100
|
|
||
32
Southern Company
SO
$96B
| $268K | 0.24% |
2,825
|
|
||
33
Eli Lilly
LLY
$946B
| $231K | 0.21% |
303
|
|
||
34
Norfolk Southern
NSC
$65.5B
| $211K | 0.19% |
+701
|
|
||
35
Verizon
VZ
$170B
| $210K | 0.19% |
4,786
|
|
||
|
36
Expeditors International
EXPD
$20.2B
| $205K | 0.18% |
+1,670
|
|
||
37
Iovance Biotherapeutics
IOVA
$977M
| $164K | 0.15% |
75,504
-31,008
|
|
||
|
38
Berkshire Hathaway Class B
BRK.B
$1.09T
| – | – |
-1,435
|
|
||
39
Amdocs
DOX
$8.62B
| – | – |
-2,237
|
|
||
|
40
Equinix
EQIX
$73.1B
| – | – |
-640
|
|
||
41
Alphabet (Google) Class A
GOOGL
$3.65T
| – | – |
-24,114
|
|
||
|
NVEE
42
DELISTED
NV5 Global
NVEE
| – | – |
-89,806
|
|
||
43
United Parcel Service
UPS
$86.6B
| – | – |
-2,127
|
|